Barusiban versus atosiban versus placebo for luteal phase uterine contractions in progesterone-supplemented oocyte donors

Phase 2, randomised, double-blind trial in There is no specific canonical disease named "uterine contraction disorder." and female infertility comparing Barusiban + vaginal progesterone, Atosiban + vaginal progesterone and Placebo + vaginal progesterone (3 arms). Primary endpoint: Frequency of uterine contractions at 3 hours after start of dosing. Started Aug 2007; status: completed.